Literature DB >> 22527229

NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease.

Graham Mackay, Kate Ahmad, Jon Stone, Cathie Sudlow, David Summers, Richard Knight, Robert Will, Sarosh R Irani, Angela Vincent, Paul Maddison.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22527229     DOI: 10.1007/s00415-012-6489-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  20 in total

1.  Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases.

Authors:  Donald A Collie; David M Summers; Robin J Sellar; James W Ironside; Sarah Cooper; Martin Zeidler; Richard Knight; Robert G Will
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

2.  Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease.

Authors:  Craig A Heath; Sarah A Cooper; Katy Murray; Andrea Lowman; Colm Henry; Margaret A MacLeod; Gillian E Stewart; Martin Zeidler; Jan M MacKenzie; James W Ironside; David M Summers; Richard S G Knight; Robert G Will
Journal:  Ann Neurol       Date:  2010-06       Impact factor: 10.422

3.  CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies.

Authors:  A Green; P Sanchez-Juan; A Ladogana; N Cuadrado-Corrales; R Sánchez-Valle; E Mitrová; K Stoeck; T Sklaviadis; J Kulczycki; U Heinemann; K Hess; D Slivarichová; A Saiz; M Calero; V Mellina; R Knight; C M van Duijn; I Zerr
Journal:  Eur J Neurol       Date:  2007-02       Impact factor: 6.089

Review 4.  Creutzfeldt-Jacob disease mimics, or how to sort out the subacute encephalopathy patient.

Authors:  Katherine Murray
Journal:  Pract Neurol       Date:  2011-02

Review 5.  NMDA receptor antibody encephalitis.

Authors:  Sarosh R Irani; Angela Vincent
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

6.  Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Authors:  Michael D Geschwind; K Meng Tan; Vanda A Lennon; Ramon F Barajas; Aissa Haman; Christopher J Klein; S Andrew Josephson; Sean J Pittock
Journal:  Arch Neurol       Date:  2008-10

7.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

8.  N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Authors:  Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

9.  Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants.

Authors:  Brian S Appleby; Kristin K Appleby; Barbara J Crain; Chiadi U Onyike; Mitchell T Wallin; Peter V Rabins
Journal:  Arch Neurol       Date:  2009-02

10.  Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106-126.

Authors:  Judyth Sassoon; Maki Daniels; David R Brown
Journal:  Mol Cell Neurosci       Date:  2004-01       Impact factor: 4.314

View more
  18 in total

1.  Presence of voltage-gated potassium channel complex antibody in a case of genetic prion disease.

Authors:  Adham Jammoul; Richard J Lederman; Jinny Tavee; Yuebing Li
Journal:  BMJ Case Rep       Date:  2014-06-05

Review 2.  Autoimmune encephalopathies.

Authors:  Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

3.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Authors:  Nuria Gresa-Arribas; Maarten J Titulaer; Abiguei Torrents; Esther Aguilar; Lindsey McCracken; Frank Leypoldt; Amy J Gleichman; Rita Balice-Gordon; Myrna R Rosenfeld; David Lynch; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-12-18       Impact factor: 44.182

4.  Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease.

Authors:  Oriol Grau-Rivera; Raquel Sánchez-Valle; Albert Saiz; José Luis Molinuevo; Reyes Bernabé; Elvira Munteis; Francesc Pujadas; Antoni Salvador; Júlia Saura; Antonio Ugarte; Maarten Titulaer; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

5.  Anti-N-Methyl-D-Aspartate Receptor Encephalitis in a Patient with Systemic Lupus Erythematosus.

Authors:  Ying Ying Wu; Yan Feng; Yue Huang; Jie Wen Zhang
Journal:  J Clin Neurol       Date:  2016-10       Impact factor: 3.077

6.  Gerstmann-Straüssler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies.

Authors:  Matthew Jones; Sola Odunsi; Daniel du Plessis; Angela Vincent; Matthew Bishop; Mark W Head; James W Ironside; David Gow
Journal:  Neurology       Date:  2014-05-09       Impact factor: 9.910

7.  Stereotypic Movements in Case of Sporadic Creutzfeldt-Jakob Disease: Possible Role of Anti-NMDA Receptor Antibodies.

Authors:  Michelle Molina; Robert Fekete
Journal:  Case Rep Neurol       Date:  2012-12-20

Review 8.  Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.

Authors:  James Varley; Angela Vincent; Sarosh R Irani
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

Review 9.  Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Authors:  Sarosh R Irani; Jeffrey M Gelfand; Adam Al-Diwani; Angela Vincent
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422

10.  Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease.

Authors:  Meghan Rossi; Simon Mead; John Collinge; Peter Rudge; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-09-22       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.